22nd International AIDS Conference

23-27 July 2018 
Amsterdam, the Netherlands

The International AIDS Conference brings together science, leadership, and community to advance treatment and prevention of HIV. 



Pellet formulation of lopinavir/ritonavir in children: 48-week evolution of viral suppression across age categories in the living study
Andrieux-Meyer I, Salami O*Omollo R, Musiime V, Wamalwa D, Maleche Obimbo E, Kekitiinwa A, Mwanga-Amumpaire J, Oyaro P, Bukusi EA, Waweru MWasunna MLee JSimon F, Lallemant M, for the LIVING STUDY GROUP

*Presenting author


Poster Discussion

TB/HIV co-treatment with super-boosted lopinavir and anti-tuberculosis treatment lowers abacavir concentration in children 
Rabie H, Tikiso T, McIlleron H, Lee J, Andrieux-Meyer I, Cotton M, Lallemant M, Denti P



Whether and why caregivers adhere to oral lopinavir/ritonavir pellets: lessons for scaling up an innovative pediatric HIV treatment in Kenya
Nöstlinger C, Nebot Giralt A, Ouma O, Nyamongo I, Salami O, Lallemant M, Lee J, Marchal B


More information: